XML 50 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
Product Revenue, Net - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Disaggregation of Revenue [Line Items]        
Revenue $ 4,986,000 $ 1,173,000 $ 7,980,000 $ 9,068,000
Contract with customer product sales gross to net accruals   0   0
Gross product revenue | Customer | AmerisourceBergen Drug Corporation        
Disaggregation of Revenue [Line Items]        
Concentration risk (percent) 26.40%   28.90%  
Gross product revenue | Customer | Cardinal Health        
Disaggregation of Revenue [Line Items]        
Concentration risk (percent) 25.20%   24.20%  
Gross product revenue | Customer | McKesson Corporation        
Disaggregation of Revenue [Line Items]        
Concentration risk (percent) 20.20%   20.90%  
IBSRELA        
Disaggregation of Revenue [Line Items]        
Revenue $ 4,900,000   $ 6,900,000  
Product sales, net        
Disaggregation of Revenue [Line Items]        
Revenue $ 4,885,000 $ 0 $ 6,899,000 $ 0